- ICH GCP
- US Clinical Trials Registry
- Researchers
- Spain
- Leukemia, Lymphocytic, Chronic, B-Cell
Medical specialists from Spain tagged as investigators in clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell
Total 82 results
-
Maria Teresa ArtolaSeen in:
- Donostia, Hospital Universitario de Donostia
Trials:- NCT05049473 (Principal Investigator)
-
Maria Victoria Mateos MantecaSeen in:
- Castilla Y León, Salamanca, Hospital Universitario de Salamanca
- Salamanca, Fundacion Instituto de Estudios Ciencias de la Salud de Castilla y Leon-Investigacion Biomedica de Salamanca (IBSAL)
- Salamanca, GSK Investigational Site
- Salamanca, Hospital Universitario de Salamanca
Trials:- NCT03215030 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT05590377 (Principal Investigator)
- NCT05849610 (Principal Investigator)
- NCT05908409 (Principal Investigator)
-
Mariana BastosSeen in:
- Madrid, Hospital Gregorio Marañón
Trials:- NCT05049473 (Principal Investigator)
-
Marta CerveraSeen in:
- Tarragona, ICO-Hospital Joan XXIII
Trials:- NCT05049473 (Principal Investigator)
-
Martinez ChamorroSeen in:
- Madrid, Pozuelo De Alarcón, Hospital Universitario Quironsalud Madrid
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Martinez del Carmen Martinez ChamorroSeen in:
- Pozuelo De Alarcón, Madrid, Hospital Universitario Quironsalud Madrid
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Natalia AlonsoSeen in:
- Santiago De Compostela, Complexo Hospitalario Santiago de Compostela
Trials:- NCT05049473 (Principal Investigator)
-
Nerea CaminosSeen in:
- Donostia, Hospital Universitario de Donostia
Trials:- NCT05049473 (Principal Investigator)
-
Patricia BaltasarSeen in:
- Madrid, Hospital Universitario La Paz
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Pau AbrisquetaSeen in:
- Barcelona, Hospital Universitari Vall d'Hebron
Trials:- NCT05049473 (Principal Investigator)
-
Pau MontesinosSeen in:
- Valencia, Hospital Universitari i Politecnic La Fe
- Valencia, Hospital Universitari i Politecnic La Fe de Valencia
- Valencia, Hospital Universitario La Fe
Trials:- NCT03589326 (Principal Investigator)
- NCT04067336 (Principal Investigator)
- NCT05049473 (Principal Investigator)
Conditions:- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL);
- Acute Myeloid Leukemia;
- Acute Leukemia of Ambiguous Lineage;
- Advanced Malignant Neoplasm;
- Mixed Phenotype Acute Leukemia;
- Mixed Lineage Leukemia;
- Mixed Lineage Acute Leukemia;
- Mature B-Cell Leukemia Burkitt Type;
- Burkitt Lymphoma (BL);
- Unclassifiable Lymphoma Between DCBL and BL
-
Pere BarbaSeen in:
- Barcelona, Hospital Universitari Vall d'Hebron
- Barcelona, Vall D'Hebron University Hospital
Trials:- NCT03589326 (Principal Investigator)
- NCT05049473 (Principal Investigator)
- NCT06281847 (Principal Investigator)
-
Pilar HerreraSeen in:
- Madrid, Hospital Ramón y Cajal
Trials:- NCT05049473 (Principal Investigator)
-
Rafael Andreu LapiedraSeen in:
- Valencia, Hospital Universitari i Politecnic La Fe
Trials:- NCT04965493 (Principal Investigator)
Conditions: -
Raul Córdoba MascuñanoSeen in:
- Madrid, Hospital Universitario Fundacion Jimenez Diaz
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT05023980 (Principal Investigator)
-
Reyes ArranzSeen in:
- Madrid, Hospital Universitario La Princesa
Trials:- NCT05049473 (Principal Investigator)
-
Rocio Figueroa MoraSeen in:
- Madrid, Clinica Universitaria de Navarra
Trials:- NCT05254743 (Principal Investigator)
-
Rodrigo MartinoSeen in:
- Barcelona, Hospital de Sant Pau
Trials:- NCT05049473 (Principal Investigator)
-
Santiago MercadalSeen in:
- Bellvitge, Ico-Hospital Duran I Reynals
Trials:- NCT05049473 (Principal Investigator)
-
Santiago PrendesSeen in:
- Planta Baja, Madrid, Hospital General Universitario Gregorio Marañón
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Teresa BernalSeen in:
- Asturias, Oviedo, Hospital Universitario Central de Asturias
- Oviedo, Hospital Central de Asturias
- Oviedo, Hospital Universitario Central de Asturia
Trials:- NCT04797780 (Principal Investigator)
- NCT05049473 (Principal Investigator)
- NCT03850574 (Principal Investigator)
-
Valentín Cabañas PerianesSeen in:
- Murcia, H. Un. Virgen de la Arrixaca
- Murcia, Hospital Clinico Universitario Virgen de La Arrixaca
- Murcia, Hospital Virgen de la Arrixaca
Trials:- NCT05558319 (Principal Investigator)
- NCT04802356 (Principal Investigator)
- NCT05908409 (Principal Investigator)
Clinical Trials on Leukemia, Lymphocytic, Chronic, B-Cell
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
Fred Hutchinson Cancer Research Center/University...WithdrawnB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance
-
OnxeoCompletedB-cell Chronic Lymphocytic LeukemiaUnited Kingdom